Cytomegalovirus and Toxoplasma gondii seroprevalence in a Brazilian liver transplant waiting

• Published in: The journal of venomous animals and toxins including tropical diseases 2007, Vol.13 (4), p.881-884
• Main Authors: Almeida, R. A. M. B.(São Paulo State University Botucatu Medical School Clinic Hospital,UNESP Botucatu Medical School Department of Tropical Diseases and Imaging Diagnosis), Silva, G. F, Llanos, J. C.(São Paulo State University Botucatu Medical School Clinic Hospital), Winckler, C. C.(São Paulo State University Botucatu Medical School Clinic Hospital), Gomes, M. R. B.(São Paulo State University Botucatu Medical School Clinic Hospital), Biagioni, D. S.(São Paulo State University Botucatu Medical School Clinic Hospital), Paula, R. C. C.(São Paulo State University Botucatu Medical School Clinic Hospital), Meira, D. A.(UNESP Botucatu Medical School Department of Tropical Diseases and Imaging Diagnosis), Bakonyi, A.(São Paulo State University Botucatu Medical School Clinic Hospital)
• Format: Article
• Language: English
• Subjects: Cytomegalovirus; liver transplantation; seroprevalence; TOXICOLOGY; Toxoplasma gondii; toxoplasmosis; TROPICAL MEDICINE; waiting list
• ISSN: 1678-9199; 1678-9199
• DOI: 10.1590/S1678-91992007000400016

Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality in solid organ transplantation. Disseminated toxoplasmosis after liver transplantation is a rare but fatal event. Serologic screening of the donor and the recipient is essential to prophylactic management, early diagnosis and therapeutic strategies to minimize the consequences of these infections. The aim of the present study was to determine the seroprevalence of CMV and Toxoplasma gondii (TG) in a Brazilian liver transplant waiting list (LTWL). Serological data were collected from 44 candidates on the LTWL between May 2003 and November 2004. Serological investigation of antibodies IgM and IgG against CMV (anti-CMV) and TG (anti-T. gondii) was performed using fluorometry commercial kits. IgG anti-CMV was positive in 37 patients (94.9%) out of 39 available results. There were not IgM anti-CMV positive results. Out of 36 analyzed patients, 22 (61.1%) presented positive IgG anti-T. gondii and none had positive IgM anti-T. gondii. The high CMV seroprevalence among our LTWL reinforces the need for appropriate protocols to avoid related complications, like reactivation and superinfection by CMV. Environmental and drug prophylactic strategies against primary infection and reactivation, as well as early diagnosis and treatment of toxoplasmosis complications, are essential for the good outcome of transplant patients.